We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$144B
AUM Growth
+$27.9B
Cap. Flow
+$22.2B
Cap. Flow %
15.4%
Top 10 Hldgs %
31.02%
Holding
7,740
New
680
Increased
3,884
Reduced
2,259
Closed
408

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Financials 5.68%
3 Healthcare 5.62%
4 Consumer Discretionary 5.04%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIVE
6626
DELISTED
VIVEVE MED INC
VIVE
$7K ﹤0.01%
2
-24
-92% -$68K
FRED
6627
PUT
DELISTED
Fred's Inc
FRED
$7K ﹤0.01%
3,600
-200
-5% -$403
MFGP
6628
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$7K ﹤0.01%
321
-66
-17% -$1.34K
WPG
6629
CALL
DELISTED
Washington Prime Group Inc.
WPG
$7K ﹤0.01%
111
SPHS
6630
DELISTED
Sophiris Bio, Inc.
SPHS
$7K ﹤0.01%
2,600
-10,800
-81% -$30.7K
ACIU icon
6631
AC Immune
ACIU
$240M
$6K ﹤0.01%
+772
New +$7.76K
AEE icon
6632
PUT
Ameren
AEE
$30.1B
$6K ﹤0.01%
100
-100
-50% -$6.3K
ASPS icon
6633
CALL
Altisource Portfolio Solutions
ASPS
$65.8M
$6K ﹤0.01%
+25
New +$6.8K
AXS icon
6634
CALL
AXIS Capital
AXS
$7.55B
$6K ﹤0.01%
100
-6,800
-99% -$385K
BWEN icon
6635
Broadwind
BWEN
$109M
$6K ﹤0.01%
2,673
+252
+10% +$570
BWXT icon
6636
PUT
BWX Technologies
BWXT
$15.6B
$6K ﹤0.01%
100
CVE icon
6637
PUT
Cenovus Energy
CVE
$52.1B
$6K ﹤0.01%
600
-1,900
-76% -$18.5K
CVM icon
6638
CEL-SCI Corp
CVM
$30.1M
$6K ﹤0.01%
+48
New +$2.76K
EARN
6639
Ellington Residential Mortgage REIT
EARN
$165M
$6K ﹤0.01%
522
-12,806
-96% -$147K
FNV icon
6640
CALL
Franco-Nevada
FNV
$46B
$6K ﹤0.01%
100
-200
-67% -$13.7K
GBX icon
6641
CALL
The Greenbrier Companies
GBX
$1.46B
$6K ﹤0.01%
100
-300
-75% -$17.3K
GNTX icon
6642
PUT
Gentex
GNTX
$5.07B
$6K ﹤0.01%
300
-2,200
-88% -$50.9K
INVA icon
6643
CALL
Innoviva
INVA
$1.48B
$6K ﹤0.01%
400
+300
+300% +$4.32K
LYG icon
6644
Lloyds Banking Group
LYG
$91.3B
$6K ﹤0.01%
2,050
RFL icon
6645
Rafael Holdings
RFL
$107M
$6K ﹤0.01%
710
-8,179
-92% -$74.6K
RIGL icon
6646
CALL
Rigel Pharmaceuticals
RIGL
$750M
$6K ﹤0.01%
200
SLM icon
6647
CALL
SLM Corp
SLM
$5.15B
$6K ﹤0.01%
500
-1,300
-72% -$15.1K
SNT
6648
Senstar Technologies
SNT
$43.2M
$6K ﹤0.01%
1,082
SSRM icon
6649
PUT
SSR Mining
SSRM
$6.48B
$6K ﹤0.01%
700
-400
-36% -$3.78K
UGI icon
6650
PUT
UGI
UGI
$7.33B
$6K ﹤0.01%
100
-100
-50% -$5.39K

Similar funds

Barclays's Q3 2018 Portfolio in Review

As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.

  • Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
  • Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
  • Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
  • Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
  • Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
  • Barclays opened 680 new positions and closed 408 in Q3 2018.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $144B.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.